Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The objective of this study is to evaluate the clinical equivalence of the test formulation of Linaclotide compared to the marketed formulation LINZESS® in patients with Chronic Idiopathic Constipation, and to evaluate the efficacy and safety of the test formulation of Linaclotide in the treatment of Chronic Idiopathic Constipation.
Epistemonikos ID: c39c3fd2e30d2d348c74af2c30d9cc73560b0677
First added on: May 08, 2024